Skip to main content

Immunome Inc.

IMNM
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001472012

In the last 90 days, Immunome Inc. insiders filed 0 open-market purchases and 7 sales; 202 institutions reported holding it in 13F filings for Q2 2026, worth $2.50B in total; no superinvestor holds it.

Q4 2024 vs. Q3 2024

How the institutions holding Immunome Inc. changed between Q3 2024 and Q4 2024.

All holders in Q4 2024All holders in Q3 2024

13F holders of IMNM: Q3 2024 compared with Q4 2024
MeasureQ3 2024Of which not filed for Q4 2024Q4 2024Change
Holders1151121+7
Shares51.6M10.6K53.3M+1.70M (+3.3%)
Value$754.7M$154.8K$566.3M−$188.2M (−24.9%)

1 institution that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (34)

Institutions that held Immunome Inc. at the end of Q4 2024 but not at the end of Q3 2024.

Institutions new to IMNM in Q4 2024
InstitutionSharesValue% of portfolio
Enavate Sciences GP, LLC3,478,261$36.9M26.53%
Granahan Investment Management Inc314,239$3.34M0.14%
Millennium Management LLC158,428$1.68M0.00%
Two Sigma Investments, LP154,467$1.64M0.00%
Citadel Advisors LLC95,866$1.02M0.00%
Cubist Systematic Strategies, LLC84,930$902.0K0.01%
Alps Advisors Inc50,470$536.0K0.00%
Two Sigma Advisers, LP48,200$511.9K0.00%
Virtu Financial LLC45,743$486.0K0.03%
Scharf Investments, LLC44,389$471.4K0.01%
Los Angeles Capital Management LLC35,721$379.4K0.00%
Three Bridge Wealth Advisors, LLC27,615$293.3K0.10%
Raymond James Financial Inc25,817$274.2K0.00%
Crestline Management, LP24,744$262.8K0.01%
Johnson Financial Group, LLC20,000$212.4K0.02%
Commonwealth Equity Services, LLC19,017$202.0K0.00%
Kennedy Capital Management, Inc.14,521$154.2K0.00%
ProShare Advisors LLC14,477$153.7K0.00%
Teacher Retirement System of Texas11,648$124.0K0.00%
Stoneridge Investment Partners LLC11,554$123.0K0.04%
Verition Fund Management LLC11,175$118.7K0.00%
Police & Firemen's Retirement System of New Jersey10,335$109.8K0.00%
Aquatic Capital Management LLC8,935$94.9K0.00%
Point72 (DIFC) Ltd7,275$77.3K0.01%
KLP Kapitalforvaltning AS7,100$75.4K0.00%
BNP Paribas Arbitrage, SA6,584$69.9K0.00%
R Squared Ltd1,410$15.0K0.01%
Aster Capital Management (DIFC) Ltd327$3.47K0.00%
Creative Planning233$2.47K0.00%
Caitong International Asset Management Co., Ltd106$1.13K0.00%
Amundi78$8310.00%
SBI Securities Co., Ltd.24$2550.00%
IFP Advisors, Inc0$2440.00%
Bear Mountain Capital, Inc.20$2040.00%

Sold out (27)

Institutions that held Immunome Inc. at the end of Q3 2024 and filed for Q4 2024 without it.

Not filed for Q4 2024 yet (1)

Institutions that held Immunome Inc. at the end of Q3 2024 and haven't filed a 13F for Q4 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding IMNM in Q3 2024 that haven't filed for Q4 2024
InstitutionShares, Q3 2024Value, Q3 2024
Raymond James & Associates10,586$154.8K